静脈血栓塞栓症（VTE）治療薬の世界市場（～2026年）

• 英文タイトル：Global Venous thromboembolism(VTE)Therapeutics Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY05000 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は静脈血栓塞栓症（VTE）治療薬のグローバル市場について調査・分析したレポートです。種類別（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他）市場規模、用途別（病院、ASC、研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別静脈血栓塞栓症（VTE）治療薬の競争状況、市場シェア ・世界の静脈血栓塞栓症（VTE）治療薬市場：種類別市場規模 2015年-2020年（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他） ・世界の静脈血栓塞栓症（VTE）治療薬市場：種類別市場規模予測 2021年-2026年（深部静脈血栓症（DVT）、肺塞栓症（PE）、その他） ・世界の静脈血栓塞栓症（VTE）治療薬市場：用途別市場規模 2015年-2020年（病院、ASC、研究所） ・世界の静脈血栓塞栓症（VTE）治療薬市場：用途別市場規模予測 2021年-2026年（病院、ASC、研究所） ・北米の静脈血栓塞栓症（VTE）治療薬市場分析：米国、カナダ ・ヨーロッパの静脈血栓塞栓症（VTE）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの静脈血栓塞栓症（VTE）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の静脈血栓塞栓症（VTE）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの静脈血栓塞栓症（VTE）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boehringer Ingelheim、Bayer、Janssen、Bristol-Myers Squibb、Pfizer、Daiichi-Sankyo、Portola Pharmaceuticals、Armetheon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Venous thromboembolism (VTE), which is composed of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a blood clot (thrombosis) of the circulatory system that leads to impeded blood flow, which can have serious consequences in the affected individual (Heit, 2015). In VTE, a DVT is a clot that occurs only in the veins; generally, they occur in the deep veins of the legs and pelvis, but may also occur in the veins of the upper body (AHA, 2017; Cohen et al., 2007; Heit, 2015). The clot may break off from its original location and travel throughout the circulatory system, and if the clot ends up in the lung, it is known as a PE 
One of the Major drivers of VTE market growth over the forecast period is the increase in patient shares towards the NOACs due to increased confidence among physicians about using these novel therapies.

Market Analysis and Insights: Global Venous thromboembolism(VTE)Therapeutics Market
The global Venous thromboembolism(VTE)Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Venous thromboembolism(VTE)Therapeutics Scope and Market Size
Venous thromboembolism(VTE)Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Venous thromboembolism(VTE)Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Boehringer Ingelheim
Bayer
Janssen
Bristol-Myers Squibb
Pfizer
Daiichi-Sankyo
Portola Pharmaceuticals
Armetheon

Market segment by Type, the product can be split into
Deep Vein Thrombosis(DVT)
Pulmonary Embolism(PE)
Others
Market segment by Application, split into
Hospital
ASCs
Research Institutes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Venous thromboembolism(VTE)Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Venous thromboembolism(VTE)Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Deep Vein Thrombosis(DVT)
1.4.3 Pulmonary Embolism(PE)
1.4.4 Others
1.5 Market by Application
1.5.1 Global Venous thromboembolism(VTE)Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 ASCs
1.5.4 Research Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Venous thromboembolism(VTE)Therapeutics Market Perspective (2015-2026)
2.2 Global Venous thromboembolism(VTE)Therapeutics Growth Trends by Regions
2.2.1 Venous thromboembolism(VTE)Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Venous thromboembolism(VTE)Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Venous thromboembolism(VTE)Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Venous thromboembolism(VTE)Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Venous thromboembolism(VTE)Therapeutics Players by Market Size
3.1.1 Global Top Venous thromboembolism(VTE)Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Venous thromboembolism(VTE)Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Venous thromboembolism(VTE)Therapeutics Market Concentration Ratio
3.2.1 Global Venous thromboembolism(VTE)Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Venous thromboembolism(VTE)Therapeutics Revenue in 2019
3.3 Venous thromboembolism(VTE)Therapeutics Key Players Head office and Area Served
3.4 Key Players Venous thromboembolism(VTE)Therapeutics Product Solution and Service
3.5 Date of Enter into Venous thromboembolism(VTE)Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Venous thromboembolism(VTE)Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)
5.2 Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
6.2 Venous thromboembolism(VTE)Therapeutics Key Players in North America (2019-2020)
6.3 North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
6.4 North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

7 Europe
7.1 Europe Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
7.2 Venous thromboembolism(VTE)Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
7.4 Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

8 China
8.1 China Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
8.2 Venous thromboembolism(VTE)Therapeutics Key Players in China (2019-2020)
8.3 China Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
8.4 China Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

9 Japan
9.1 Japan Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
9.2 Venous thromboembolism(VTE)Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
9.4 Japan Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
10.2 Venous thromboembolism(VTE)Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

11 India
11.1 India Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
11.2 Venous thromboembolism(VTE)Therapeutics Key Players in India (2019-2020)
11.3 India Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
11.4 India Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Venous thromboembolism(VTE)Therapeutics Market Size (2015-2020)
12.2 Venous thromboembolism(VTE)Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Details
13.1.2 Boehringer Ingelheim Business Overview
13.1.3 Boehringer Ingelheim Venous thromboembolism(VTE)Therapeutics Introduction
13.1.4 Boehringer Ingelheim Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020))
13.1.5 Boehringer Ingelheim Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Venous thromboembolism(VTE)Therapeutics Introduction
13.2.4 Bayer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Janssen
13.3.1 Janssen Company Details
13.3.2 Janssen Business Overview
13.3.3 Janssen Venous thromboembolism(VTE)Therapeutics Introduction
13.3.4 Janssen Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.3.5 Janssen Recent Development
13.4 Bristol-Myers Squibb
13.4.1 Bristol-Myers Squibb Company Details
13.4.2 Bristol-Myers Squibb Business Overview
13.4.3 Bristol-Myers Squibb Venous thromboembolism(VTE)Therapeutics Introduction
13.4.4 Bristol-Myers Squibb Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.4.5 Bristol-Myers Squibb Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Venous thromboembolism(VTE)Therapeutics Introduction
13.5.4 Pfizer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Daiichi-Sankyo
13.6.1 Daiichi-Sankyo Company Details
13.6.2 Daiichi-Sankyo Business Overview
13.6.3 Daiichi-Sankyo Venous thromboembolism(VTE)Therapeutics Introduction
13.6.4 Daiichi-Sankyo Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.6.5 Daiichi-Sankyo Recent Development
13.7 Portola Pharmaceuticals
13.7.1 Portola Pharmaceuticals Company Details
13.7.2 Portola Pharmaceuticals Business Overview
13.7.3 Portola Pharmaceuticals Venous thromboembolism(VTE)Therapeutics Introduction
13.7.4 Portola Pharmaceuticals Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.7.5 Portola Pharmaceuticals Recent Development
13.8 Armetheon
13.8.1 Armetheon Company Details
13.8.2 Armetheon Business Overview
13.8.3 Armetheon Venous thromboembolism(VTE)Therapeutics Introduction
13.8.4 Armetheon Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020)
13.8.5 Armetheon Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Venous thromboembolism(VTE)Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Venous thromboembolism(VTE)Therapeutics Revenue
Table 3. Ranking of Global Top Venous thromboembolism(VTE)Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Venous thromboembolism(VTE)Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Deep Vein Thrombosis(DVT)
Table 6. Key Players of Pulmonary Embolism(PE)
Table 7. Key Players of Others
Table 8. Global Venous thromboembolism(VTE)Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Venous thromboembolism(VTE)Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Venous thromboembolism(VTE)Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Venous thromboembolism(VTE)Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Venous thromboembolism(VTE)Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Venous thromboembolism(VTE)Therapeutics Players
Table 19. Global Venous thromboembolism(VTE)Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Venous thromboembolism(VTE)Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Venous thromboembolism(VTE)Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous thromboembolism(VTE)Therapeutics as of 2019)
Table 22. Global Venous thromboembolism(VTE)Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Venous thromboembolism(VTE)Therapeutics Product Solution and Service
Table 25. Date of Enter into Venous thromboembolism(VTE)Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Venous thromboembolism(VTE)Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Venous thromboembolism(VTE)Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Venous thromboembolism(VTE)Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Venous thromboembolism(VTE)Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 35. North America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 37. North America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 41. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 47. China Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 49. China Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 53. Japan Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 65. India Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 67. India Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Venous thromboembolism(VTE)Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Venous thromboembolism(VTE)Therapeutics Market Share (2019-2020)
Table 71. Central & South America Venous thromboembolism(VTE)Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Venous thromboembolism(VTE)Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Venous thromboembolism(VTE)Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Venous thromboembolism(VTE)Therapeutics Market Share by Application (2015-2020)
Table 75. Boehringer Ingelheim Company Details
Table 76. Boehringer Ingelheim Business Overview
Table 77. Boehringer Ingelheim Product
Table 78. Boehringer Ingelheim Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 79. Boehringer Ingelheim Recent Development
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. Janssen Company Details
Table 86. Janssen Business Overview
Table 87. Janssen Product
Table 88. Janssen Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 89. Janssen Recent Development
Table 90. Bristol-Myers Squibb Company Details
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Product
Table 93. Bristol-Myers Squibb Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 99. Pfizer Recent Development
Table 100. Daiichi-Sankyo Company Details
Table 101. Daiichi-Sankyo Business Overview
Table 102. Daiichi-Sankyo Product
Table 103. Daiichi-Sankyo Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 104. Daiichi-Sankyo Recent Development
Table 105. Portola Pharmaceuticals Company Details
Table 106. Portola Pharmaceuticals Business Overview
Table 107. Portola Pharmaceuticals Product
Table 108. Portola Pharmaceuticals Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 109. Portola Pharmaceuticals Recent Development
Table 110. Armetheon Business Overview
Table 111. Armetheon Product
Table 112. Armetheon Company Details
Table 113. Armetheon Revenue in Venous thromboembolism(VTE)Therapeutics Business (2015-2020) (Million US$)
Table 114. Armetheon Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Venous thromboembolism(VTE)Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Deep Vein Thrombosis(DVT) Features
Figure 3. Pulmonary Embolism(PE) Features
Figure 4. Others Features
Figure 5. Global Venous thromboembolism(VTE)Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. ASCs Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Venous thromboembolism(VTE)Therapeutics Report Years Considered
Figure 10. Global Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Venous thromboembolism(VTE)Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Venous thromboembolism(VTE)Therapeutics Market Share by Players in 2019
Figure 15. Global Top Venous thromboembolism(VTE)Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Venous thromboembolism(VTE)Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Venous thromboembolism(VTE)Therapeutics Revenue in 2019
Figure 17. North America Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Venous thromboembolism(VTE)Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

---